CHICAGO, Dec. 11, 2019 /PRNewswire/ -- Ronald L Chez, a private investor, files a 13D for Alimera Sciences, Inc. (NASDAQ: ALIM). Alimera returns to growth in the 3rd quarter and expects continued progress in the 4th quarter. The Company is in a strong position to succeed with their unique approach to DME.
Media contact: Elias Matsakis, Holland & Knight LLP
SOURCE Ronald L. Chez, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
Newsrooms &
Influencers
9k+
Digital Media
Outlets
Digital Media
Outlets
270k+
Journalists
Opted In
Journalists
Opted In
Share this article